We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Swp4.0
Saw Palmetto Research
Likely helps
82 peer-reviewed studies
What the evidence says
Probably helps
Saw Palmetto helped in about half (6/9) of the studies that measured an effect — promising, but not unanimous.
Most evidence is from high-quality meta-analyses and randomised trials published 2002–2026 with a typical study size of 320 participants.
Based on 82 studies · 11 meta-analyses · 54 RCTs · 48,084 total participants
Confidence
High confidence
What the studies found
6helped3unclear· 73 more without graded effect data
By outcome
BPH & lower urinary tract symptoms
Likely helps73 studies
Men's vitalityInhibits 5-alpha reductase, but clinical hormonal effect is unproven · 4-12 weeks · Rigorous trials found it no better than placebo for BPH symptoms · 4-8 weeks
Mostly mechanism / observational16 studies
Safety profile
Mostly mechanism / observational16 studies
Therapeutic & clinical
Mostly mechanism / observational9 studies
Skin health
Mostly mechanism / observational8 studies
Women's health
Mostly mechanism / observational3 studies
Inflammation
Too few graded studies2 studies
Heart & blood pressure
Too few graded studies1 study
By the numbers
Pulled from 39 studies with measurable effects
Likely real effects
40%
across studies
People studied
48k
typical study: 320 people
Strongest designs
65
11 pooled, 54 randomised
Showed benefit
67%
6/9 studies
How long studies ran
1–3 months
5
3+ months
4
Populations Studied
Men with BPH10
Men with lower urinary tract symptoms2
General population2
Men with benign prostatic enlargement1
Active research area
26 studies in the last 5 years · Latest meta-analysis: 2024
200220142026
1BPH symptomsSystematic Reviewn=5,000 · very large study2012
Saw palmetto was not superior to placebo for BPH symptoms.
Tacklind J et al. · Cochrane Database of Systematic Reviews (2012)
Natural products such as rosemary, green tea, ginseng, Aloe vera, olive, and saw palmetto have shown promising efficacy in promoting hair growth, improving hair density, reducing hair shedding, and enhancing patient satisfaction through mechanisms involving anti-inflammatory, hormonal, and enhanced scalp circulation.
Allam AT et al. · Naunyn-Schmiedeberg's archives of pharmacology (2025)
However, study design limitations and outcome variability necessitate further rigorous, standardized research.
This review aims to offer an integrative, evidence-informed perspective on the therapeutic potential of herbal medicine for hair loss in clinical evidence.
11Concurrent prescription drugs and herbal medicine use prevalenceSystematic ReviewCited 69×2017
The prevalence of concurrent prescription drugs and HMP use among older adults is substantial and potential interactions have been reported.
Agbabiaka TB et al. · Drugs & aging (2017)
No clear effect
← WorseNo effectBetter →
Prevalence of concurrent use by older adults varied widely between 5.3 and 88.3%.
The prevalence of concurrent prescription drugs and HMP use among older adults is substantial and potential interactions have been reported.
Knowledge of the extent and manner in which older adults combine prescription drugs will aid healthcare professionals in appropriately identifying and managing patients at risk.
13quality of lifeReviewn=4,656 · very large study2023
Serenoa repens alone provides little to no benefits for men with lower urinary tract symptoms due to benign prostatic enlargement.
Franco JV et al. · The Cochrane database of systematic reviews (2023)
No clear effect
← WorseNo effectBetter →
Serenoa repens results in little to no difference in the quality of life at short-term follow-up (3 to 6 months; IPSS quality of life domain range 0 to 6, higher scores indicate worse quality of life; MD -0.20, 95% CI -0.40 to -0.00; I2 = 39%; 5 studies, 1001 participants; high-certainty evidence).
Serenoa repens probably results in little to no difference in adverse events (1 to 17 months; risk ratio (RR) 1.01, 95% CI 0.77 to 1.31; I2 = 18%; 12 studies, 2399 participants; moderate-certainty evidence).
Serenoa repens results in little to no difference in urologic symptoms at long-term follow-up (12 to 17 months, IPSS score, MD 0.07, 95% CI -0.75 to 0.88; I2 = 34%; 3 studies, 898 participants; high-certainty evidence).
While the significance of many interactions is uncertain, several interactions, particularly those with St John's wort, may have serious clinical consequences.
Izzo AA et al. · Drugs (2009)
Echinacea might affect the clearance of caffeine (a CYP1A2 probe) and midazolam (a CYP3A4 probe).
No interactions have been reported for saw palmetto (Serenoa repens).
Numerous interactions between herbal medicines and conventional drugs have been documented.
20Adverse events assessmentSystematic ReviewCited 53×n=26 · very small study2009
However, higher quality reporting of adverse events is essential if safety assessments are to be improved in future.
Agbabiaka TB et al. · Drug safety (2009)
Currently available data suggest that S. repens is well tolerated by most users and is not associated with serious adverse events.
The majority of adverse events are mild, infrequent and reversible, and include abdominal pain, diarrhoea, nausea and fatigue, headache, decreased libido and rhinitis.
We found no evidence for drug interactions with S. repens.